Azenta Q3 revenue flat at $144M; non-GAAP EPS $0.19 vs $0.14 YoY; reaffirms FY2025 guidance

Azenta, Inc.

2025-Q3 EPS reported -$2.33 revenue$434,870,000

Revenue $144M flat YoY; organic revenue down 2%. Sample Management Solutions -4%, Multiomics +4%.
Non-GAAP diluted EPS $0.19 (vs $0.14); GAAP EPS from cont ops $0.01 (vs ($0.00)).
Adjusted EBITDA $18M, margin 12.3% (+260 bps); operating cash flow $26M, FCF $15M.
FY2025 guidance reaffirmed: organic growth 3-5% and ~300 bps EBITDA margin expansion.
Discontinued ops (B Medical) $50M non-cash impairment; total diluted EPS ($1.15).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.